Detailed Curriculum Vitae

21 April 2016:

Title and license of Medical Specialty Endocrinology, Diabetes Mellitus and Metabolism, Region of Attica, Department of Public Health.

20 February 2008:

Doctor of Medicine, Ph.D. Thesis Title, Subject:  “The Adrenal Axis in Diabetes.” Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Aghia Sophia Children’s Hospital, Adult Diabetes Clinic, First Department of Propeadeutic and Internal Medicine, Laikon Hospital, Chair: Professor George P. Chrousos, National and Kapodistrian University of Athens, Medical School.

11 July 2001:

Doctor of Medicine, M.D., Democritus University of Thrace, Medical School.

07/2008 – 07/2010:

National Institutes of Health (NIH), Bethesda, Maryland, USA. Clinical & Research Fellowship Program in Adult & Reproductive Endocrinology, Eunice Kennedy Shriver, National Institute of Child Health & Human Development (NICHD).

04/2006 – 04/2008:

National and Kapodistrian University of Athens, Medical School, Greece. Clinical Fellowship Program in Endocrinology. Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Aghia Sophia Children’s Hospital, Adult Endocrine Unit,Evgenidion Hospital.

10/2003 – 02/2008:

National and Kapodistrian University of Athens, Medical School, Greece. Ph.D. Dissertation Subject: “The Adrenal Axis in Diabetes.” Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Children’s Hospital “Aghia Sophia”, Adult Diabetes Clinic, First Department of Propaedeutic and Internal Medicine, Hospital “Laiko”, Chair: Professor George P. Chrousos.

05/2004 – 02/2006:

1st Hospital of Athens “Penteli”, A’ Internal Medicine Clinic, Social Security Foundation (SSF-IKA), Athens, Greece.

09/2001 – 12/2002:

General Prefectural Hospital of Amfissa, Itea Medical Center, Desfina Regional Hospital.

10/1995-07/2001:

Democritus University of Thrace, Medical School, Doctor of Medicine (MD), Greece.

01/2019–present:

Director of Endocrinology, Diabetes and Metabolism. Neuroendocrinology, Neuroendocrine and Endocrine Tumors, Thyroid cancer, Gynecological Endocrinology-Gynecological Endocrinology, Endocrinology of Pregnancy, Transitional Endocrinology, Athens Medical Center, “Iatriko”, Greece.

05/2018:

Tenure-track offer after interview for the post of Consultant in Diabetes, Endocrinology and General Internal Medicine. Centre for Endocrinology and Diabetes, St. James’ University Hospital, The Leeds Teaching Hospitals NHS Foundation Trust, National Health Service (NHS), UK.

11/2017 – 11/2018:

Locum Consultant in Endocrinology, Diabetes and General Internal Medicine, Endocrine and Diabetes Unit, Royal Victoria Infirmary, Freeman & General Hospitals, Newcastle upon Tyne Hospitals NHS Foundation Trust, University of Newcastle upon Tyne, National Health Service England (NHS), UK.

04/2017 – 09/2017:

Locum Consultant in Endocrinology, Diabetes and General Internal Medicine, Endocrine and Diabetes Unit, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, and James Cook University Hospital, South Tees NHS Foundation Trust, National Health Service England (NHS), UK.

11/2016 – 04/2017:

Honorary Fellow in Medicine, UEMS Exchange in Endocrinology Expertise, Endocrine and Diabetes Unit, Royal Victoria Infirmary and Freeman Hospitals, Newcastle upon Tyne Hospitals NHS Foundation Trust, University of Newcastle upon Tyne, National Health Service (NHS), UK.

09/2013 – 06/2016:

Scientific Associate, National and Kapodistrian University of Athens, Medical School, Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieio Hospital, Greece.

04/2012 – 07/2013:

Research Associate, Wayne State University, USA. Program in Perinatal Research and Obstetrics, Perinatology Research Branch, Maternal-Fetal Medicine, National Institute of Child Health and Human Development (NICHD/NIH), Hutzel Women’s Hospital, School of Medicine, Wayne State University, Detroit, Michigan, USA.

07/2008 – 07/2013:

Post-Doctoral Visiting Fellow w/ Clinical Privileges, National Institutes of Health (NIH), USA. Clinical & Research Fellowship Program in Adult and Reproductive Endocrinology, Section on Medical Neuroendocrinology, Developmental Endocrine Oncology and Genetics, National Institute of Child Health and Human Development (NICHD/NIH), Clinical Neuroendocrinology Branch, National Institute of Mental Health (NIMH/NIH), Department of Laboratory Medicine, Special Chemistry Laboratory & Mass Spectrometry, NIH Clinical Center, Bethesda, Maryland, USA.

11/2012:

Certificate of Completion, Compliance Training, Wayne State University, Detroit, Michigan, USA.

07/2010:

Certificate of Completion, Radiation Safety in Laboratory Training, Division of Radiation Safety (DRS), National Institutes of Health (NIH), Bethesda, Maryland, USA.

06/2010:

Certificate of Completion, Contamination Control Training, Division of Radiation Safety, National Institutes of Health (NIH), Bethesda, Maryland, USA.

06/2010:

Certificate of Completion, Radiation Safety Orientation Training, Division of Radiation Safety, (DRS), National Institutes of Health (NIH), Bethesda, Maryland, USA.

06/2010:

LC/MS User Meeting, Agilent/LC/MS two-day conference – Workshop User on QQQ LC/MS (Day 1), and Workshop User on TOF-Q-TOF LC/MS (Day 2), Gerstel, Inc. on June 22-23, Linthicum, Maryland, USA.

06/2010:

New Developments in Metabolomics, Marriott, Bethesda, Maryland, USA

03/2010:

Mass-Spectrometry Hands-on & Theory on QQQ & QTF by Agilent, Delaware, USA.

03/2010:

Mass-Spectrometry and Proteomics, Pharma Cadence, March 12-23, Philadelphia, USA.

03/2010:

Mass-Spectrometry Hands-on & Theory on QQQ by Agilent, Department of Laboratory Medicine, Special Chemistry Laboratory & Mass-Spectrometry, National Institutes of Health (NIH), Clinical Center, Bethesda, Maryland, USA.

09/2009:

A Review of Endocrinology: Diagnosis and Treatment, the Foundation for Advanced Education in the Sciences (FAES) graduate school, the National Institutes of Health(NIH), and the George Washington University Medical Center, September 8-12, 2009, Bethesda, Maryland, USA.

04/2009:

Certificate of Completion, Mouse Workshop, Office of Animal Care and Use (OACU), National Institutes of Health (NIH), Bethesda, Maryland, USA.

04/2009:

Certificate of Completion, Working Safely with HIV & other Bloodborne Pathogens Safety, Division of Occupational Health and Safety (DOHS), National Institutes of Health (NIH), Bethesda, Maryland, USA.

03/2009:

Certificate of Completion, Guidelines for Animal Users, Office of Animal Care and Use (OACU), National Institutes of Health (NIH), Bethesda, Maryland, USA.

01/2009:

Certificate of Completion, Short-term Course in Human Embryonic Stem Cell Culture, Stem Cell Biology Research, Johns Hopkins University, January 12-16, 2009, Baltimore, Maryland, USA.

09 – 12/2008:

Certificate of Completion, Stem cells and their Niches: Jump Start for University Teaching, Foundation for Advanced Education in the Sciences, (FAES), September 15 – December 19, National Institutes of Health (NIH), Bethesda, Maryland, USA.

09 – 12/2008:

Statistics for Biomedical Science, Foundation for Advanced Education in the Sciences (FAES), September 15 – December 19, National Institutes of Health (NIH), Bethesda, Maryland, USA.

12/2008:

Certificate of Completion, Basic life support for Health Care Providers (CPR & AED), American Heart Association.

12/2008:

Certificate of Completion, Clinical Research Information System (CRIS) Training, Department of Clinical Research Informatics (DCRI), National Institutes of Health (NIH), Clinical Center, Bethesda, Maryland, USA.

07 – 08/2007:

Adjunct Scientist, National Institutes of Health (NIH), Bethesda, Maryland, USA, Bench Research on the Glucocorticoid Receptor Signalling System at the Reproductive Biology and Medicine Branch (RBMB), Eunice Kennedy Shriver, National Institute of Child Health and Human Development (NICHD/NIH), Bench Research on the Neural Stem Cell Biology at the Molecular Biology Laboratory, National Institute of Neurological Disorders and Stroke (NINDS/NIH).

10/2023:

Obesity School, Obesity Schools, Novo Nordisk, Athens, Greece.

10/2022:

Obesity School, Obesity Schools, Novo Nordisk, Athens, Greece.

11/2021:

1st Obesity School, Obesity Schools, Novo Nordisk, Athens, Greece.

01/2020:

Postgraduate Courses in Endocrinology, Diabetes and Metabolism, “Evagelismos” Hospital, 15-17 January, Royal Olympic, Athens, Greece.

10/2016:

Introduction to Good Medical Practice, National Institute for Health Research (NIHR), National Health Service England (NHS), UK.

01/2014:

Intensive Training in Endocrinology, Hellenic Endocrinology Society, 20-24 January, Athens, Greece.

02 – 03/2007:

European Society for Paediatric Endocrinology (ESPE), Winter School, Paediatric Endocrinology, 24 February-2 March, Prague, Czech Republic.

2004 – 2005:

Courses in Endocrinology, Hellenic Endocrine Society, Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Agia Sophia Children’s Hospital (Choremio), National and Kapodistrian University of Athens, Medical School, Athens, Greece.

12/2004:

3rd International Workshop, Highlights in Basic and Clinical Neuroendocrinology, University of Athens, December 4, Athens, Greece.

11/2004:

European Resuscitation Council 2004 «BLS/AED Provider Course,» Athens, Greece.

07/2004:

3rd Trier Summer School of Psychobiology: Stress, Metabolism and the Hypothalamic-Pituitary-Adrenal Axis, July 14-16, Trier, Germany.

2016-2017

“MEREO Hypogonadal Study”, National Institute for Health Research (NIHR), Newcastle Clinical Research Facility (CRF), Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust.

01/2016:

European Union of Medical Specialists (UEMS) Award, Section and Board of Endocrinology “Exchange in Endocrinology Expertise” EU.

06/2012 – 08/2013:

US Government Award/Scholarship, National Institutes of Health (NIH), USA.

07/2011 – 06/2012:

US Government Award/Scholarship, National Institutes of Health (NIH), USA.

07/2010 – 07/2011:

US Government Award/Scholarship, National Institutes of Health (NIH), USA.

07/2008 – 07/2010:

US Government Award/Scholarship, National Institutes of Health (NIH), USA.

07/2009:

Stanley Medical Research Institute, Postmortem Brain Tissue donated for research on human brain tissues, USA.

01/2007:

Kapodistrias Program Research Funding 2007, National and Kapodistrian University of Athens-Special Research Funds Account, Medical School, Athens, Greece.

01/2019–present:

Neuroendocrinology clinic, Neuroendocrine and Endocrine Tumors clinics, Gynecological Endocrinology, Endocrinology of Pregnancy, Transitional Endocrinology clinics, Athens Medical Centre.

11/2017 – 11/2018:

Outpatients clinics: Joint Endocrine Clinic, Rapid Access Clinic, Antenatal Joint Clinic, Diabetic Clinic, Neuroendocrine Tumor (NET) Clinic

 Multidisciplinary Team (MDT) Meetings, Neuroendocrine Tumor (NET), Thyroid Cancer and Endocrine Multiple Disciplinary Team Meetings, Endocrine and Diabetes Unit, Royal Victoria Infirmary, Freeman and General Hospitals, Newcastle Upon Tyne Hospitals NHS Foundation Trust, University of Newcastle upon Tyne, NHS, UK

04 – 09/2017:

Outpatients clinics: Endocrine Clinic, Antenatal Joint Clinic, Diabetic Clinic, Endocrine and Diabetes Unit, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, and James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, NHS, UK.

11/2016-present:

Full Registration with a License to Practice, Full with Specialist Registration with a License to Practice Endocrinology and Diabetes, General Medical Council (GMC), UK, GMC#: 7554998.

04/2016:

Title of Speciality Endocrinology, Diabetes & Metabolism, Greece.

08/2001-present:

Medical Licensure, Athens Medical Association (ISA), Athens, Greece, ISA #: 053771.

• General Medical Council (UK)
• Athens Medical Association (Greece)
• Hellenic Endocrinology Society (Greece)

• Clinical Endocrinology (Reviewer)
• Metabolism (Reviewer)
• Clinical Biochemistry (Reviewer)
• American Journal of Obstetrics and Gynaecology (Reviewer)
• Journal of Endocrinological Investigation (Reviewer)

11/2017 – 11/2018:

Clinical Supervision and Education of 8 Specialty Trainee in Endocrinology, Endocrine and Diabetes Unit, Royal Victoria Infirmary, Freeman and General Hospitals, Newcastle Upon, Tyne Hospitals, NHS Foundation Trust, University of Newcastle upon Tyne, NHS, UK.

04 – 09/2017:

Clinical Supervision and Education of 13 Specialty trainee in Endocrinology, Endocrine and Diabetes Unit, William Harvey Hospital and East Kent Hospitals University, NHS Foundation Trust, NHS, UK.

09 – 12/2008:

Co-instructor in: «Insights into Stem Cells and Their Niches», Foundation for Advanced Education in the Sciences (FAES), National Institutes of Health (NIH), Bethesda, Maryland, USA.

07/2016:

English: «International English Language Testing System» (IELTS Academic), British Council/Cambridge English

06/2004:

English: «Advanced Level Certificate in English» (ALCE), Hellenic American Union

10/1991:

French: «Certificate in French», French Institute of Studies

Endocrine Society’s 94th Annual Meeting: Endo 2012. Houston, TX. “Haploinsufficiency May Explain Partial Glucocorticoid, Androgen, and, Thyroid Hormone Resistance Associated with 16p11.2 Microdeletion”.

Endocrine Society’s 93th Annual Meeting: Endo 2011. Boston, MA. “Circulating Cortisol- Associated Signature of Glucocorticoid-related Gene Expression in Subcutaneous Fat of Obese Subjects”.

European Association for the Study of Diabetes: 44th Annual Meeting 2008. Rome. “Fort and Ford: Two Novel Assays for the Assessment of Oxidative Stress in Patients with Newly Diagnosed Diabetes Mellitus Type 2”.

Endocrine Society’s 89th Annual Meeting: Endo 2007. Toronto. “Chronic Angiotensin II Receptor Antagonism Increases Retinol-Binding Protein 4, Improves Metabolic Profile’s and Inflammation’s Markers and Resets the Hypothalamic-Pituitary-Adrenal Axis of Patients with Diabetes Mellitus Type 2: A Pilot Study”.

Endocrine Society’s 88th Annual Meeting: Endo 2006. Boston, MA. “Angiotensin II Receptor Antagonist Therapy Suppresses Hypothalamic Pituitary Adrenal Axis Function in Patients with Impaired Glucose Tolerance and Diabetes Mellitus Type.”

“Functional Adrenal Neoplasms”. Continuous Medical Education, Athens Medical Center, 2 February 2022, Athens, Greece.

“Endocrine Disorders in Pregnancy”. Continuous Medical Education, Athens Medical Center, 19 May 2021, Athens, Greece.

“Sexual Dysfunction, Endocrine Approach”, Athens Medical Center, 26 May 2021, Athens, Greece.

“The Diabetic Patient with Cardiovascular Disease. Newer Therapeutical Choices”. Research Institute for Longevity and Prevention of Senescence Diseases, Developments in Cardiovascular Medicine, 5-7 December 2019, Athens, Greece.

“Neuroendocrine Tumors”. Continuous Medical Education, Athens Medical Center, 29 January 2020, Athens, Greece.

“Calcium and Calcium Regulating Hormones in Depressive Illness. The role of Klotho, Vitamin D and Regulated Molecules”. Program in Perinatal Research and Obstetrics, Perinatology Research Branch, Maternal-Fetal Medicine, National Institute of Child Health and Human Development (NICHD/NIH), Hutzel Women’s Hospital, School of Medicine, Wayne State University, Detroit, Michigan.

1. Maria G. Pavlatou, Miloš Žarković, Laszlo Hegedüs, Julia Priestley, Cheryl McMullan, Petros Perros. A survey on the psychological impact and access to health care of thyroid patients during the first SARS-COV-2 lockdown. Clin. Endocrinol (Oxf). 2021 Epub ahead of print
2. Dimitra Pappa, Maria G. Pavlatou, Katerina Skenderi, Maria Papastamataki, George Mastorakos, George P. Chrousos, Maria Tsironi, and Ioannis Papassotiriou. “Effect of an ultra-distance foot race on the hypothalamic-pituitary testicular adrenocortical axes insulin growth factor levels: distinct patterns of suppression, stimulation and recovery”. Ann Res Hosp. 2019 Feb 03; 3:5.
3. Maria G. Pavlatou, Remaley A.T, Gold P.W. “Klotho: A Humeral Mediator in CSF and Plasma that Influences Longevity and Susceptibility to Multiple Complex Disorders, Including Depression.” Transl. Psychiatry. 2016 Aug 30; 6(8): e876.
4. Luiz HV, Tanchee MJ, Pavlatou MG, Yu R, Nambuba J, Wolf K, Prodanov T, Wesley R, Adams K, Fojo T, Pacak K. “Are patients with hormonally functional pheochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.” Clin Endocrinol (Oxf). 2016 Jul; 85(1): 62-9.
5. Gold PW, Pavlatou MG, Michelson D, Mouro CM, Kling MA, Wong ML, Licinio J, Goldstein SA. “Chronic Administration of Anticonvulsants but not Antidepressants Impairs Bone Strength: Clinical Implications.” Transl Psychiatry. 2015 June; e576.
6. Gold PW, Machado-Vieira R, Pavlatou MG. “Clinical and Biochemical Manifestations of Depression: Relation to the Neurobiology of Stress.” Neural Plast. 2015 March; 581976.
7. Maria G. Pavlatou, Kasey C. Vickers, Sudhir Varma, Rana Malek, Maureen Sampson, Alan T. Remaley, Philip W. Gold, Monica C. Skarulis, Tomoshige Kino. “Circulating Cortisol- Associated Signature of Glucocorticoid-related Gene Expression in Subcutaneous Fat of Obese Subjects.” Obesity (Silver Spring). 2013 May; 21(5): 960–967.
8. Philip W. Gold, Licinio J, Pavlatou MG. “Pathological Parainflammation and Endoplasmic Reticulum Stress in Depression: Potential Translational Targets through the CNS Insulin, Klotho and PPAR-γ Systems.” Mol. Psychiatry 2013 18, 154–165.
9. Gold PW, Pavlatou MG, Carlson PJ, Luckenbaugh DA, Costello R, Bonne O, Csako G, Drevets WC, Remaley AT, Charney DS, Neumeister A, Kling MA. “Unmedicated, Remitted Patients with Major Depression Have Decreased Serum Immunoglobulin A.” Neurosci. Lett. 2012 June; 1-5
10. Kino T*, Pavlatou MG*, Moraitis AG, Nemery RL, Raygada M, Stratakis CA. “ZNF764 Haploinsufficiency May Explain Partial Glucocorticoid, Androgen, and Thyroid Hormone Resistance Associated with 16p11.2 Microdeletion.” JCEM 2012; E1557-66. *These authors contributed equally to this work.
11. Maria G. Pavlatou, George Mastorakos, Alexandra Margeli, Evangelia Kouskouni, Nicholas Tentolouris, Nikos Katsilambros, George P. Chrousos and Ioannis Papassotiriou. “Angiotensin Blockade in Diabetic Patients Decreases Insulin Resistance-Associated Low- Grade Inflammation.” EJCI 2010 Dec; 652-8.
12. Maria G. Pavlatou, Maria Papastamataki, Filia Apostolakou, Ioannis Papassotiriou, Nicholas Tentolouris. “FORT and FORD: 2 Simple and Rapid Assays in the Evaluation of Oxidative Stress in Patients with Type 2 Diabetes Mellitus.” Metabolism 2009 Nov; 1657-62.
13. Maria G. Pavlatou, Mastorakos G, Lekakis I, Liatis S, Vamvakou G, Zoumakis E, Papassotiriou I, Rabavilas AD, Katsilambros N, Chrousos GP. “Chronic Administration of an Angiotensin II Receptor Antagonist Resets the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Improves the Affect of Patients with Diabetes Mellitus Type 2: Preliminary Results.” Stress 2007 Jul: 1-11.
14. Mastorakos G., Pavlatou MG, M Mizamtsidi. “The Hypothalamic-Pituitary-Adrenal and the Hypothalamic-Pituitary- Gonadal axes Interplay.” Pediatric Endocrinology Reviews Jan 2006, 1; 172-182.
15. Mastorakos G., Pavlatou M. “Exercise as a Stress Model and the Interplay between the Hypothalamic Pituitary-Adrenal and the Hypothalamic-Pituitary-Thyroid Axes.” Hormone and Metabolic Research, Sept 2005, 37 (9); 577-584.
16. Mastorakos G., Pavlatou M., E. Diamanti-Kandarakis, G.P. Chrousos. “Exercise and the Stress System.” Hormones (Athens), 2005 April-June, 4(2): 73-89.
17. Mastorakos G., Pavlatou M. “Exercise and the Stress System.” Obstetricia Ginecologia. 2004 Jul, Νο 4.

1. 1. Maria G Pavlatou, Sarah J Johnson, Petros Perros. Practical Management of Thyroid Cancer ‐ A Multidisciplinary Approach, Second edition. Springer Nature. 2018
   2. Mastorakos G., Pavlatou. “Exercise and Female Endocrine Regulations.” In press.
   3. Mastorakos G., Pavlatou, N. Salakos. “The Mechanisms of Stress in Athletes.” Athens, 2007; 12.
   4. Mastorakos G., Pavlatou, and I. Ilias. “Hypothalamic-Pituitary-Adrenal axis and the Gonadal axis” in the book: “Reproductive Endocrinology in Woman and Man.” Thessaloniki, 2004; 31:481-497.